XML 74 R40.htm IDEA: XBRL DOCUMENT v3.20.1
STOCKHOLDERS' EQUITY AND STOCK-BASED COMPENSATION - Stock Options Activity (Details) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Number of Options    
Outstanding, Beginning Balance, Number of Options 75,062 142,502
Granted, Number of Options
Exercised, Number of Options (41,310) (67,440)
Expired/Forfeited, Number of Options (502)  
Outstanding, Ending Balance, Number of Options 33,250 75,062
Weighted Average Exercise Price    
Outstanding, Beginning Balance, Weighted Average Exercise Price $ 7.95 $ 8.19
Granted, Weighted Average Exercise Price
Exercised, Weighted Average Exercise Price 6.62 8.45
Expired/Forfeited, Weighted Average Exercise Price 6.00  
Outstanding, Ending Balance, Weighted Average Exercise Price $ 9.64 $ 7.95
Additional information    
Options Outstanding, Weighted Average Remaining Contractual Term 10 months 24 days  
Options exercisable at end of year (in shares) 33,250 75,062
Options exercisable at end of year, Weighted Average Exercise Price $ 9.64 $ 7.95
Stock Options [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Shares authorized under plan 1,650,000  
Shares available for grant 364,928  
Number of Options    
Granted, Number of Options 0 0
Additional information    
Weighted average remaining contractual term 4 months 24 days  
Grant date fair value of options outstanding and exercisable $ 148,000 $ 224,000
Fair value of options exercised 75,000 183,000
Total intrinsic value of options exercised $ 313,000 $ 494,000